Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

Women’s health tech NextGen Jane raises $9 million for novel diagnostics

ImpactAlpha, March 3 – Oakland-based NextGen Jane is a women’s “wearables” technology company, of sorts, that is trying to improve early reproductive health diagnosis. Its diagnostic tool? Tampons.

“Every single month during your period, your body is providing you with a natural biopsy when it sheds your endometrial lining,” the company writes on its website. “What could we learn if we had the tools to listen?”  

Its service allows women to mail-in used tampon samples to test for early signs of disease. It markets itself as a convenient and more comfortable alternative to gynecologist’s speculum and stirrups. 

NextGen Jane is currently in beta testing. It has raised $9 million in a Series A round led by Material Impact, which invests in “groundbreaking materials-based technologies that have the capacity to democratize access to the resources we need most.” Access Industries, Viking Global Investors and Liminal Ventures also participated.

NextGen Jane joins a growing group of health and consumer tech startups focusing on women’s issues. Bangalore-based Naramai just raised $6 million for an affordable breast cancer screening device. Lagos-based Stack Diagnostics secured seed funding for early cancer screening in a region where late- or undiagnosed cervical cancer is often fatal for women. And numerous startups are launching and raising funding to make better, more affordable sanitary products for women, both in wealthy markets (like Rael) and lower-income countries (like Bana, Afri-pads and SHE.)

You might also like...